Fundraising FoxCaixa Capital Risc — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)inCarole Guillonneau(Co-founder & Head of Research)inFrançois-Xavier Hubert(Co-founder, Past President & Board Member)
Co-investorsCriteria Bio VenturesNewton BiocapitalSound BioventuresSambrinvestWallonie Entreprendre
flowww is management software for clinics and centers in the beauty, aesthetic medicine, health, and wellness sectors, offering digital medical records with e-signatures, appointment booking, stock traceability, automated marketing, and real-time analytics.
Digital HealthSaaSWellness & Fitness
Co-investorsSwanlaab Venture Factory
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.